NPPA issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 500mg + Glimepiride IP 2mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Unison Pharmaceuticals Pvt. Ltd. (Marketer)

Mar 09, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 06, 2026, issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 500mg + Glimepiride IP 2mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Unison Pharmaceuticals Pvt. Ltd. (Marketer).

It states that the price for each hard gelatin capsule containing: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 500mg + Glimepiride IP 2mg has been fixed at Rs. 11.90/- excluding GST.

[Notification no. - 19(5057)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT